STOML2 knockdown inhibits inflammation and airway remodeling of PDGF-BB-induced airway smooth-muscle cells by the MAPK pathway
Our results showed that silencing STOML2 inhibits inflammation and airway remodeling in PDGF-BB-stimulated HASMCs via the p38 MAPK pathway. Thus, STOML2 is a promising therapeutic target for the treatment of asthma.
Authors
- Songbai Zhu
- Zhen Li (ORCID: https://orcid.org/0000-0002-9101-0364)
Institutions
- Hubei Provincial Women and Children's Hospital (CN)
- Wuhan Third Hospital (CN)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1080/02770903.2025.2546358
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94